N. Borsellino

Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma.

V. Gebbia, V. Leonardi, G. Savio, 2004, Anticancer research.

Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule

N. Gebbia, M. Latteri, V. Gebbia, 2005, Journal of Cancer Research and Clinical Oncology.

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

N. Gebbia, M. Latteri, V. Gebbia, 1993, Anti-cancer drugs.

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.

M. Valerio, N. Gebbia, G. Colucci, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.

D. Galetta, G. Colucci, E. Maiello, 2015, Clinical lung cancer.

Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).

D. Galetta, G. Colucci, V. Gebbia, 2005, Anticancer research.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

S. Barni, R. Labianca, G. Luporini, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE).

D. Galetta, G. Colucci, E. Maiello, 2011, Clinical lung cancer.

Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale.

D. Galetta, G. Colucci, V. Gebbia, 2002, Lung cancer.

Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

A. Rossi, C. Gridelli, V. Gebbia, 2003, Anticancer research.

F1 PERIOPERATIVE ANEMIA AND BLOOD TRANSFUSIONS AS PROGNOSTIC FACTORS IN PATIENTS UNDERGOING RESECTION FOR NON-SMALL CELL LUNG CANCERS

D. Galetta, V. Catalano, M., 2005 .